0001493152-20-000166.txt : 20200103 0001493152-20-000166.hdr.sgml : 20200103 20200103191104 ACCESSION NUMBER: 0001493152-20-000166 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200101 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreiber Christopher C CENTRAL INDEX KEY: 0001750076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 20507630 MAIL ADDRESS: STREET 1: AKERS BIOSCIENCES, INC. STREET 2: 201 GROVE ROAD CITY: THOROFARE STATE: NJ ZIP: 08086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0306 4 2020-01-01 0 0001321834 Akers Biosciences, Inc. AKER 0001750076 Schreiber Christopher C C/O TAGLICH BROTHERS INC 709 NEW YORK AVENUE.SUITE 209 HUNTINGTON NY 11743 1 1 0 0 Executive Chairman Common Stock 2020-01-01 4 M 0 5201 A 5201 D Restricted Stock Units 2020-01-01 4 M 0 5201 0.00 A Common Stock 5201 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company"). On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020. /s/ Christopher C. Schreiber 2020-01-03